From its beginnings in 1887 as a packager of generic home remedies, Perrigo, headquartered in Ireland, has grown to become the world’s largest manufacturer of OTC products and supplier of infant formulas for the store brand market. The company is also a leading provider of branded OTC products, generic extended topical prescription products and receives royalties from Multiple Sclerosis drug Tysabri®. Perrigo provides “Quality Affordable Healthcare Products®” across a wide variety of product categories and geographies primarily in North America, Europe, and Australia, as well as other key markets including Israel and China.
For further information visit: www.perrigo.com
In multiple sclerosis the myelin sheath surrounding neurons is attacked by the body’s defence systems resulting in the slowing down of the signal or even its blockage. Even if a signal is just slowed down it will cause responses to go out of synch and become ineffective.